✦ LIBER ✦

Clinicopathologic Significance of Loss of CD19 Expression in Diffuse Large B-Cell Lymphoma

✍ Scribed by Miho Kimura; Motoko Yamaguchi; Shigeo Nakamura; Hiroshi Imai; Satoshi Ueno; Shoko Ogawa; Kana Miyazaki; Kouji Oka; Toshiyuki Ohno; Kenkichi Kita; Tohru Kobayashi; Hiroshi Shiku

Book ID: 111835635
Publisher: Carden Jennings Publishing
Year: 2007
Tongue: English
Weight: 780 KB
Volume: 85
Category: Article
ISSN: 0925-5710
DOI: 10.1532/ijh97.06148

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

FOXP1 expression and its clinicopatholog

FOXP1 expression and its clinicopathologic significance in nodal and extranodal diffuse large B-cell lymphoma

✍ BaoHua Yu; XiaoYan Zhou; BaiZhou Li; XiuYing Xiao; ShiYan Yan; DaRen Shi 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 238 KB

Prognostic clinicopathologic factors, in

Prognostic clinicopathologic factors, including immunologic expression in diffuse large B-cell lymphomas

✍ Anmin Zhang; Koichi Ohshima; Kensaku Sato; Motonobu Kanda; Junji Suzumiya; Kae S 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 906 KB

Gene expression profiling of diffuse lar

Gene expression profiling of diffuse large B-cell lymphoma supervised by CD21 expression

✍ Kana Miyazaki; Motoko Yamaguchi; Miyuki Suguro; Woonyoung Choi; Yuan Ji; Lianchu 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 387 KB

Prognostic significance of pSTAT3 and Su

Prognostic significance of pSTAT3 and Survivin expression in diffuse large B-cell lymphoma

✍ Ji-Youn Sung; Sung-Jig Lim; Youn Wha Kim; Juhie Lee 📂 Article 📅 2010 🏛 Wiley (Blackwell Publishing) 🌐 English ⚖ 392 KB

Role of CD21 antigen in diffuse large B-

Role of CD21 antigen in diffuse large B-cell lymphoma and its clinical significance

✍ Masaki Otsuka; Yoshihiro Yakushijin; Makoto Hamada; Takaaki Hato; Masaki Yasukaw 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 335 KB

Biomarkers of potential prognostic signi

Biomarkers of potential prognostic significance in diffuse large B-cell lymphoma

✍ Grace Wu; Armand Keating 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 116 KB

## Abstract Diffuse large B‐cell lymphoma (DLBCL) is a biologically heterogeneous disease for which the current approach to treatment is only successful for 50% of patients. The prognostic value of various clinical and biological factors in predicting treatment outcome is discussed in this paper. A